Federal health regulators have found tiny particles of trash in drugs made by Genzyme, the second time this year the biotechnology company has been cited for contamination issues. Despite those problems, the FDA said the products would remain on the market, because there are few alternative treatments. |
Read the rest of the story HERE:

At hosted.ap.org
Sheila Samples is an Oklahoma writer and a former civilian US Army Public Information Officer. She is a Managing Editor for OpEd News, and a regular contributor for a variety of Internet sites.